ATARA BIOTHERAPEUTICS INC's ticker is ATRA and the CUSIP is 046513107. A total of 124 filers reported holding ATARA BIOTHERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.01 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $2,059,748 | -3.4% | 710,258 | +9.3% | 0.01% | -22.2% |
Q4 2022 | $2,131,272 | -16.3% | 649,778 | -3.6% | 0.02% | -33.3% |
Q3 2022 | $2,547,000 | -15.7% | 673,779 | +73.7% | 0.03% | -3.6% |
Q2 2022 | $3,022,000 | -16.0% | 387,937 | +0.2% | 0.03% | +33.3% |
Q1 2022 | $3,596,000 | -9.8% | 387,085 | +53.0% | 0.02% | 0.0% |
Q4 2021 | $3,986,000 | +81.4% | 252,923 | +106.1% | 0.02% | +40.0% |
Q3 2021 | $2,197,000 | -10.6% | 122,717 | -22.4% | 0.02% | 0.0% |
Q2 2021 | $2,458,000 | -13.2% | 158,097 | -19.8% | 0.02% | -21.1% |
Q1 2021 | $2,831,000 | +569.3% | 197,137 | +814.6% | 0.02% | +375.0% |
Q4 2020 | $423,000 | -54.2% | 21,555 | -69.8% | 0.00% | -63.6% |
Q3 2020 | $924,000 | +75.7% | 71,329 | +97.5% | 0.01% | +57.1% |
Q2 2020 | $526,000 | -49.5% | 36,113 | -42.8% | 0.01% | -56.2% |
Q4 2019 | $1,041,000 | -54.7% | 63,189 | -61.1% | 0.02% | -55.6% |
Q3 2019 | $2,296,000 | -4.5% | 162,624 | +36.1% | 0.04% | -14.3% |
Q2 2019 | $2,403,000 | -6.9% | 119,506 | +84.1% | 0.04% | 0.0% |
Q1 2019 | $2,580,000 | – | 64,899 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Antipodean Advisors LLC | 1,000,000 | $1,480,000 | 7.58% |
Redmile Group, LLC | 6,280,813 | $9,295,603 | 0.44% |
Arctis Global LLC | 397,046 | $587,628 | 0.32% |
Baupost Group | 9,773,616 | $14,465 | 0.28% |
JOSH ARNOLD INVESTMENT CONSULTANT, LLC | 230,000 | $413,400 | 0.24% |
MAVERICK CAPITAL LTD | 6,290,713 | $9,310,255 | 0.21% |
683 Capital Management, LLC | 1,200,000 | $1,776,000 | 0.14% |
STALEY CAPITAL ADVISERS INC | 1,000,000 | $1,480,000 | 0.08% |
WASATCH ADVISORS LP | 8,399,229 | $12,430,859 | 0.08% |
PACIFIC HEIGHTS ASSET MANAGEMENT LLC | 525,000 | $777,000 | 0.07% |